These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28272220)

  • 1. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
    Zhang M; Li H; Ji Z; Dong D; Yan S
    Medicine (Baltimore); 2017 Mar; 96(10):e6243. PubMed ID: 28272220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
    Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome.
    Giannantoni A; Porena M; Gubbiotti M; Maddonni S; Di Stasi SM
    Urology; 2014 Feb; 83(2):400-5. PubMed ID: 24231216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Persistent Somatoform Pain Disorder by Floating Needle Therapy and Duloxetine].
    Ren WW; Zhou ZY; Xu MM; Long S; Tang GZ; Mao HJ; Chen SL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):166-71. PubMed ID: 27078991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acupuncture on quality of life in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
    Wang H; Ji Y; Zhang S; Yuan P; Zhao H; Guo Y; Xie X; Ding Y
    Zhongguo Zhen Jiu; 2024 Apr; 44(4):411-417. PubMed ID: 38621728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
    BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Sevim M; Alkiş O; Kartal İG; Kazan HO; İvelik Hİ; Aras B; Kabay Ş
    Prostate; 2023 Jun; 83(8):751-758. PubMed ID: 36871235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
    Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
    Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anticholinergic therapy based on the upoint system in the treatment of chronic prostatitis.
    Narter KF; Can U; Coşkun A; Sabuncu K; Tarhan F
    Arch Ital Urol Androl; 2019 Mar; 91(1):16-21. PubMed ID: 30932424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Electroacupuncture with Different Waveforms on Chronic Prostatitis/Chronic Pelvic Pain Syndromes: A Randomized Controlled Trial.
    Li Z; Liu J; Liu P; Zhang Y; Han W
    Contrast Media Mol Imaging; 2022; 2022():6866000. PubMed ID: 35935300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
    Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
    Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
    Nickel JC; Johnston B; Downey J; Barkin J; Pommerville P; Gregoire M; Ramsey E
    Urology; 2000 Sep; 56(3):413-7. PubMed ID: 10962305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
    Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
    PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
    Tuğcu V; Taşçi AI; Fazlioğlu A; Gürbüz G; Ozbek E; Sahin S; Kurtuluş F; Cek M
    Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.